0001415889-19-001479.txt : 20191212
0001415889-19-001479.hdr.sgml : 20191212
20191211195037
ACCESSION NUMBER: 0001415889-19-001479
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20191212
DATE AS OF CHANGE: 20191211
EFFECTIVENESS DATE: 20191212
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: VistaGen Therapeutics, Inc.
CENTRAL INDEX KEY: 0001411685
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205093315
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-355353
FILM NUMBER: 191280800
BUSINESS ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-577-3600
MAIL ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Excaliber Enterprises, Ltd.
DATE OF NAME CHANGE: 20070906
D
1
primary_doc.xml
X0708
D
LIVE
0001411685
VistaGen Therapeutics, Inc.
343 Allerton Avenue
South San Francisco
CA
CALIFORNIA
94080
650-577-3600
NEVADA
None
Excaliber Enterprises, Ltd.
Corporation
true
Shawn
K.
Singh
343 Allerton Avenue
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Director
Jerrold
D.
Dotson
343 Allerton Avenue
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
H.
Ralph
Snodgrass
343 Allerton Avenue
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Director
Jon
S.
Saxe
343 Allerton Avenue
South San Francisco
CA
CALIFORNIA
94080
Director
Brian
J.
Underdown
343 Allerton Avenue
South San Francisco
CA
CALIFORNIA
94080
Director
Jerry
B.
Gin
343 Allerton Ave.
South San Francisco
CA
CALIFORNIA
94080
Director
Mark
A.
Smith
343 Allerton Ave.
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Mark
A.
McPartland
343 Allerton Ave.
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Ann
K.
Cunningham
343 Allerton Ave.
South San Francisco
CA
CALIFORNIA
94080
Director
Biotechnology
Decline to Disclose
- 06b
false
2019-10-30
false
true
true
false
0
650000
650000
0
false
0
7
0
0
0
VistaGen Therapeutics, Inc.
/s/ Jerrold D. Dotson
Jerrold D. Dotson
Chief Financial Officer
2019-12-11